Omalizumab superior to oral immunotherapy for multifood allergy, and most patients consume allergy-triggering foods after gaining tolerance.
Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract ...
Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results